Andere Kunden interessierten sich auch für
![Access to The EU and Hungary Fruit Juice Market]( "Access to The EU and Hungary Fruit Juice Market")
Access to The EU and Hungary Fruit Juice Market22,99 €![SPS Measures and Market Access Implications for Agricultural Trade]( "SPS Measures and Market Access Implications for Agricultural Trade")
SPS Measures and Market Access Implications for Agricultural Trade26,99 €![Does the UK need access to the Single Market? What trade alternatives are there?]( "Does the UK need access to the Single Market? What trade alternatives are there?")
Does the UK need access to the Single Market? What trade alternatives are there?17,95 €![How Multinational Companies Influence Multilateral Negotiations]( "How Multinational Companies Influence Multilateral Negotiations")
How Multinational Companies Influence Multilateral Negotiations32,99 €![Global Sanitation and Urban Areas in the Current Era]( "Global Sanitation and Urban Areas in the Current Era")
Global Sanitation and Urban Areas in the Current Era23,99 €![International Business with Cesim Global Challenge Simulation Access Card + Connect Plus]( "International Business with Cesim Global Challenge Simulation Access Card + Connect Plus")
International Business with Cesim Global Challenge Simulation Access Card + Connect Plus419,99 €![International Business with Connect Plus Access Code: Competing in the Global Marketplace]( "International Business with Connect Plus Access Code: Competing in the Global Marketplace")
International Business with Connect Plus Access Code: Competing in the Global Marketplace397,99 €
An analysis of the state of access to essential medicines in Kenya within the WTO TRIPS Framework. The study focuses on Kenya as a case study and examines Kenya's utilization of three TRIPS flexibilities namely: a) compulsory licensing for domestic use, b) importation under compulsory licensing (Paragraph 6 waiver- Decision of 30th August 2003) and c) parallel importation/grey imports. Within this context, this paper will also examine whether there is tension between the right to access essential medicines by patients on one hand, and the rights of patent holders of pharmaceutical products on the other hand and how the WTO has tried to strike a balance between these (competing) interests.